1. Home
  2. DNLI vs ARLP Comparison

DNLI vs ARLP Comparison

Compare DNLI & ARLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • ARLP
  • Stock Information
  • Founded
  • DNLI 2013
  • ARLP 1971
  • Country
  • DNLI United States
  • ARLP United States
  • Employees
  • DNLI N/A
  • ARLP N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • ARLP Coal Mining
  • Sector
  • DNLI Health Care
  • ARLP Energy
  • Exchange
  • DNLI Nasdaq
  • ARLP Nasdaq
  • Market Cap
  • DNLI 3.3B
  • ARLP 3.2B
  • IPO Year
  • DNLI 2017
  • ARLP 1999
  • Fundamental
  • Price
  • DNLI $21.43
  • ARLP $25.72
  • Analyst Decision
  • DNLI Strong Buy
  • ARLP Strong Buy
  • Analyst Count
  • DNLI 11
  • ARLP 1
  • Target Price
  • DNLI $40.40
  • ARLP $27.00
  • AVG Volume (30 Days)
  • DNLI 815.8K
  • ARLP 301.3K
  • Earning Date
  • DNLI 11-06-2024
  • ARLP 01-27-2025
  • Dividend Yield
  • DNLI N/A
  • ARLP 10.89%
  • EPS Growth
  • DNLI N/A
  • ARLP N/A
  • EPS
  • DNLI N/A
  • ARLP 3.52
  • Revenue
  • DNLI N/A
  • ARLP $2,484,038,000.00
  • Revenue This Year
  • DNLI N/A
  • ARLP N/A
  • Revenue Next Year
  • DNLI $420.35
  • ARLP N/A
  • P/E Ratio
  • DNLI N/A
  • ARLP $7.31
  • Revenue Growth
  • DNLI 204.74
  • ARLP N/A
  • 52 Week Low
  • DNLI $14.56
  • ARLP $18.32
  • 52 Week High
  • DNLI $33.33
  • ARLP $29.44
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 31.13
  • ARLP 41.28
  • Support Level
  • DNLI $22.61
  • ARLP $25.28
  • Resistance Level
  • DNLI $24.15
  • ARLP $26.89
  • Average True Range (ATR)
  • DNLI 1.09
  • ARLP 0.79
  • MACD
  • DNLI -0.15
  • ARLP -0.21
  • Stochastic Oscillator
  • DNLI 7.59
  • ARLP 13.38

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About ARLP Alliance Resource Partners L.P. Common Units representing Limited Partners Interests

Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.

Share on Social Networks: